| Bioactivity | Acarbose (BAY g 5421) sulfate, antihyperglycemic agent, is an orally active alpha-glucosidase inhibitor (IC50=11 nM). Acarbose sulfate can potentiate the hypoglycemic effects of sulfonylureas or insulin[1][2][3]. |
| Invitro | Acarbose (1, 2, and 3 μM) dose- and time-dependently inhibits TNF-α-induced VSMC proliferation and migration. Acarbose (1, 2, and 3 μM) dose-dependently decreases β-galactosidase, Ras expression and increased p-AMPK expression in TNF-α pre-treated A7r5 cells[2]. |
| Name | Acarbose sulfate |
| CAS | 1221158-13-9 |
| Formula | C25H45NO22S |
| Molar Mass | 743.68 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Acarbose sulfate
CAS: 1221158-13-9 F: C25H45NO22S W: 743.68
Acarbose (BAY g 5421) sulfate, antihyperglycemic agent, is an orally active alpha-glucosidase inhibitor (IC50=11 nM). Ac
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.